AMAG signs European partner as they hunt cash to get their lead drug through the clinic
AMAG has been hard-up for cash for a while now, beset by lagging sales and the threat of a drug being pulled off the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
